Question 1

What is the catalog number for (4aS,6aS,7S,8R,9aS,9bS) -7,8-dihydroxy-7- (2-hydroxyacetyl) -4a,6a-dimethyl-5a,6,6a,7,8,9,9a,9b,10,11-decahydrocyclopenta[1,2]phenanthro[4,4a-b]oxiren-2 (4aH) -one (Budesonide Impurity)?

Accepted Answer

The catalog number for (4aS,6aS,7S,8R,9aS,9bS) -7,8-dihydroxy-7- (2-hydroxyacetyl) -4a,6a-dimethyl-5a,6,6a,7,8,9,9a,9b,10,11-decahydrocyclopenta[1,2]phenanthro[4,4a-b]oxiren-2 (4aH) -one (Budesonide Impurity) is OR1100446.

Question 2

Is (4aS,6aS,7S,8R,9aS,9bS) -7,8-dihydroxy-7- (2-hydroxyacetyl) -4a,6a-dimethyl-5a,6,6a,7,8,9,9a,9b,10,11-decahydrocyclopenta[1,2]phenanthro[4,4a-b]oxiren-2 (4aH) -one (Budesonide Impurity) in stock?

Accepted Answer

(4aS,6aS,7S,8R,9aS,9bS) -7,8-dihydroxy-7- (2-hydroxyacetyl) -4a,6a-dimethyl-5a,6,6a,7,8,9,9a,9b,10,11-decahydrocyclopenta[1,2]phenanthro[4,4a-b]oxiren-2 (4aH) -one (Budesonide Impurity)

Selected Variant

OR1100446

Size: 100 mg

Product Specifications

CAS Number

215095-77-5

Purity

98%

Smiles

O=C1C=C[C@@] (C23C (C[C@@] ([C@] (C (CO) =O) (O) [C@H] (O) C4) (C) [C@]4 ([H]) [C@]3 ([H]) CC5) O2) (C) C5=C1

Question 3

What applications has this product been validated for?

Accepted Answer

Validated applications such as WB, ELISA, IHC, ICC, or FC are listed on the product datasheet. If you need application-specific validation data before ordering, contact our technical support team with the catalogue number.

Question 4

How do I reconstitute this lyophilized product?

Accepted Answer

Reconstitution instructions, including the recommended diluent and final concentration, are provided on the datasheet. Aliquot immediately after reconstitution to avoid repeated freeze-thaw cycles.

Question 5

What is the recommended incubation time for this antibody?

Accepted Answer

A suggested incubation time is provided in the recommended protocol on the datasheet, but may need adjusting depending on your sample type and detection system.